Related Experiment Video
Updated: Sep 17, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
The association between stress hyperglycemia and poor outcome in critically ill children is modulated by
Wenjun Liu1, Milan Dong2, Jing Li1
1Department of Critical Care Medicine, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, Chongqing, China.
Insights
Hyperlactatemia (HL) modulates stress hyperglycemia (SHG) in critically ill children. Combined SHG and HL predict poor outcomes, while SHG alone does not, suggesting tailored glucose targets are needed.
Area of Science:
- Pediatric Critical Care Medicine
- Metabolic Regulation in Critical Illness
- Biomarker Interactions in Pediatric Patients
Background:
- Evidence on optimal glycemic control in critically ill children is conflicting.
- The interplay between glucose and lactate levels and their impact on outcomes in pediatric critical care remains poorly understood.
Purpose of the Study:
- To investigate the role of hyperlactatemia (HL) in modifying the association between stress hyperglycemia (SHG) and adverse outcomes.
- To inform the development of individualized glucose management strategies for critically ill children.
Main Methods:
- Secondary analysis of a prospective observational cohort study in five Chinese Pediatric Intensive Care Units (PICUs).
- Examined interaction effects between glucose and lactate metrics on patient outcomes.
- Defined SHG as glucose > 150 mg/dL and HL as lactate > 2 mmol/L.
Main Results:
- Analysis included 433 pediatric patients and 4885 blood gas measurements; 20.8% mortality within 28 days.
- Significant interaction between SHG and HL on outcomes (p < 0.05).
- In the presence of HL, SHG independently predicted 28-day mortality (OR 3.55) and reduced ventilator-free and ICU-free days. SHG alone did not predict mortality or reduced free days.
Conclusions:
- Hyperlactatemia appears to modulate the relationship between stress hyperglycemia and poor outcomes in critically ill children.
- The combination of SHG and HL is associated with adverse outcomes, whereas SHG in the absence of HL is not.
Background:
The available evidence on tight glycemic control is conflicting, while the interaction between glucose and lactate in critically ill children remains unclear.
Objective:
To explore the potential role of hyperlactatemia (HL) in modulating the relationship between stress hyperglycemia (SHG) and poor outcomes, aiming to establish tailored glucose targets in critically ill children.
Methods:
This was a secondary analysis of a prospective observational cohort study conducted in five Pediatric Intensive Care Units (PICU) in southwestern China (ChiCTR2000030846). The interaction effect between glucose and lactate metrics concerning outcomes and subsequent subgroup regression analysis was conducted. SHG was defined as glucose > 150 mg/dL(8.3mmol/L) and HL as lactate > 2 mmol/L.
Results:
A cohort of 433 pediatric patients with 4885 arterial blood gas measurements were finally enrolled. 90 (20.8%) cases died within 28 days of PICU admission. Significant interaction effects between SHG and HL on outcomes were observed (p < 0.05). In the non-HL group, SHG was not an independent predictor of 28-day mortality (p = 0.656) and was not correlated with either 28-day ventilator-free days (p = 0.916) or 28-day ICU-free days (p = 0.914). In contrast, in the HL group, SHG was independently associated with 28-day mortality (OR 3.55, 95% CI 1.62~7.80, p = 0.002) and correlated with a reduction of 5.04 28-day ventilator-free days (p = 0.003) and 4.10 28-day ICU-free days (p = 0.004).
Conclusions:
HL potentially modulates the correlation between SHG and poor outcomes in pediatric critically ill patients. Combined SHG and HL are associated with poor outcomes, whereas SHG without HL is not.
More Related Videos
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
09:35A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
Published on: November 15, 2024
Related Concept Videos
Hypoglycemia and Glucagon
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Psychoneuroimmunology: Diabetes and Cancer
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational